Summary
- Current Price
- EVOK price is unknown, with unknown change on
- Current Price All-Time High
- EVOK price vs all-time high is unknown
- Market Cap
- EVOK market cap is unknown, with unknown 1-year change
- PE Ratio
- EVOK PE ratio is unknown
- Revenue
- EVOK current annual revenue is $10.25M, up +97.84% year-over-year
- Next Earnings
- As of today, the next earnings release for EVOK has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Evoke Pharma, Inc. |
| Ticker | NASDAQ: EVOK |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | evokepharma.com |
| Employees | 3 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| - | ||
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| N/A | - | |
| $10M | ||
| Revenue, 1Y Change | +97.84% | |
| -$2.81 | ||
| EPS, 1Y Change | +89.96% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:12 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$2.81 | ||
| EPS Estimate | N/A | -$1.88 |
| EPS Est. Change | N/A | +33.08% |
| $10.25M | ||
| Revenue Estimate | N/A | $15.97M |
| Revenue Est. Change | N/A | +55.84% |
| - | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.23 | -$27.97 | -1,154.29% | |
| -$3.98 | -$2.81 | +29.41% | |
| -$1.88 | N/A | +33.08% | |
| $0.68 | N/A | +124.20% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $5.14M | $5.18M | +0.79% | |
| $10.02M | $10.25M | +2.25% | |
| $15.97M | N/A | +55.84% | |
| $25.24M | N/A | +146.21% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| +97.84% | ||
| +533.42% | ||
| +89.96% | ||
| +92.65% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| - | ||
| N/A | - | |
| SMA 200 vs Price | N/A | - |
| N/A | - | |
| SMA 50 vs Price | N/A | - |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $10.25M | ||
| -$2.81 | ||
| $9.89M | ||
| 96.52% | ||
| -$5.20M | ||
| -50.77% | ||
| -$5.35M | ||
| -52.22% | ||
| -$4.85M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.73 | ||
| 1.66 | ||
| 1.62 | ||
| - | ||
| 3 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $7.04M | ||
| $13.60M | ||
| $17.52M | ||
| $17.24M | ||
| $10.48M | ||
| $10.38M | ||
| $5.16M | ||
| $5.06M | ||
| $2.34M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $15.45M | ||
| $15.10M | ||
| $356.50K | ||
| $15.08M | ||
| - | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$5.46M | ||
| $0.00 | ||
| $14.32M | ||
| $0.00 | ||
| -$5.46M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| H.C. Wainwright | → | |
| Seaport Global | ||
| Laidlaw & Co. | → | |
| Rodman & Renshaw | → | |
| Noble Financial | → | |
| Rodman & Renshaw | → | |
| Brean Capital | → | |
| Northland Securities | ||
| Ascendiant Capital |
Analyst sentiment
Institutional ownership
Screeners with EVOK
FAQ
What is the ticker symbol for Evoke Pharma, Inc.?
The ticker symbol for Evoke Pharma, Inc. is NASDAQ:EVOK
Does Evoke Pharma, Inc. pay dividends?
No, Evoke Pharma, Inc. does not pay dividends
What sector is Evoke Pharma, Inc. in?
Evoke Pharma, Inc. is in the Healthcare sector
What industry is Evoke Pharma, Inc. in?
Evoke Pharma, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Evoke Pharma, Inc. based in?
Evoke Pharma, Inc. is headquartered in United States
When did Evoke Pharma, Inc. go public?
Evoke Pharma, Inc. initial public offering (IPO) was on September 25, 2013
Is Evoke Pharma, Inc. in the S&P 500?
No, Evoke Pharma, Inc. is not included in the S&P 500 index
Is Evoke Pharma, Inc. in the NASDAQ 100?
No, Evoke Pharma, Inc. is not included in the NASDAQ 100 index
Is Evoke Pharma, Inc. in the Dow Jones?
No, Evoke Pharma, Inc. is not included in the Dow Jones index
When was Evoke Pharma, Inc. last earnings report?
Evoke Pharma, Inc.'s most recent earnings report was on November 7, 2024
When does Evoke Pharma, Inc. report earnings?
The date for Evoke Pharma, Inc.'s next earnings report has not been announced yet
Data Sources & References
- EVOK Official Website www.evokepharma.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1403708/000095017025038712/0000950170-25-038712-index.htm
- EVOK Profile on Yahoo Finance finance.yahoo.com/quote/EVOK
- EVOK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/evok